Research offers hope to people with rare eye cancer Uveal Melanoma

The London Clinic has joined forces with Barts Cancer Research and Queen Mary, University of London amongst other health partners, in research to help patients with a rare type of eye cancer live longer.

The rare eye cancer – uveal melanoma – affects around 600-700 new cases each year in the UK. When the disease spreads to the liver, treatment options are limited, and most people live less than two years. Because it is so rare, large clinical trials are difficult to carry out, giving doctors little evidence to guide care.

Professor Hemant Kocher, a London Clinic consultant surgeon, is Professor of Liver and Pancreas Surgery at the Barts Cancer Institute, and Queen Mary, University of London. Professor Kocher and colleagues looked back at the records of 58 people treated between 2010 and 2024 at Barts Health NHS Trust and The London Clinic.

The research set out to see whether careful monitoring and more active removal of metastases of patients with a rare type of eye cancer were associated with longer survival.

Find out more here.

Read Margaret’s story and her involvement in the clinical trial here.